On July 31, 2025, the United States Department of Justice (DOJ) announced a pair of settlements with companies accused of having violated the False Claims Act (FCA) by falsely representing their compliance with certain cybersecurity requirements applicable to federal contractors. These two settlements highlight key aspects of DOJ’s enforcement priorities: (1) DOJ’s strong focus on enforcing the FCA in the cybersecurity space, and (2) DOJ’s willingness to reward companies that self-disclose violations. All government contractors certifying compliance with regulatory and contractual requirements must stay vigilant and take the steps needed to comply. 

On June 23, 2025, the United States Court of Appeals for the Ninth Circuit affirmed a district court judgment in a case in which the jury found the defendant knowingly made false statements on customs forms to avoid paying duties on Chinese imports. The decision affirms an expansive application of the False Claims Act (“FCA”) that plays directly into the hands of the Trump administration’s evolving enforcement priorities.

This in-depth webinar examines DOJ’s enforcement priorities and topics such as recent False Claims Act settlements (which go beyond health care fraud), enforcement risks and best practices, and whistleblower risks and protections from an employment law perspective.

The first 120 days of the Trump administration have been characterized by dramatic changes in the realm of white-collar enforcement. Recently issued memoranda and policy guidance from DOJ contains critical details regarding the new administration’s enforcement priorities.  

Our 2025 edition of EnforceMintz reflects on health care enforcement trends, predicts how health care enforcement may evolve, and offers practical guidance about what these trends and predictions mean for health care providers, payors, and other stakeholders.

As opioid-related enforcement efforts continued across the opioid supply chain in 2024, the government pursued criminal charges in two matters that resulted in significant settlements. Additionally, a number of recent cases against pharmacies involve a common theory of liability based on the Controlled Substances Act, which served as the basis for civil liability under the False Claims Act.

Over the past two years, the Department of Justice has actively incentivized companies to voluntarily self-disclose potential civil and criminal violations. This article explores the DOJ’s new policies, the benefits of self-disclosure, and the challenges companies face in complying with these initiatives.

The United States Attorney’s Office for the District of Massachusetts recently unsealed what it described as the “first-ever criminal charges against financial services firms for market manipulation and ‘wash trading’ in the cryptocurrency industry.” 

Read about DOJ recent scrutiny of private equity deals, its initiatives aimed at increasing acquirer oversight of M&A transactions, and best practices for private equity sponsors in the current enforcement landscape.

In March 2024, at the American Bar Association’s 39th National Institute on White Collar Crime, Deputy Attorney General (“DAG”) Lisa Monaco announced that the Department of Justice (“DOJ” or the “Department”) intended to create a new whistleblower rewards pilot program.